Volume 100, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Chagas disease (CD), caused by infection with the parasite , leads to severe cardiomyopathy in 20–30% of patients, whereas the remainder may stay asymptomatic and never develop cardiomyopathy or other clinical manifestations. The underlying cause for this variable outcome is not fully characterized, although previous studies have found high levels of circulating mannose-binding lectin (MBL) to be associated with cardiac failure echocardiographic changes. We report three indeterminate (asymptomatic) chronic Chagas patients who were followed up for 10 years. Two of these patients developed chronic chagasic cardiomyopathy (CCC) during this follow-up period and, when genotyped, were found to be carriers of the high MBL producer / genotype, suggesting that genetically determined high MBL serum might be associated with the risk of CCC development. These results suggest the use of MBL quantification and genotyping as tools for clinical assessment in patients with chronic CD.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Rassi A, Marin-Neto JA, , 2010. Chagas disease. Lancet 375: 13881402. [Google Scholar]
  2. Moncayo A, , 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98: 577591. [Google Scholar]
  3. Luz PR, Miyazaki MI, Chiminacio Neto N, Padeski MC, Barros ACM, Boldt ABW, Messias-Reason IJ, , 2016. Genetically determined MBL deficiency is associated with protection against chronic cardiomyopathy in Chagas disease. PLoS Negl Trop Dis 10: e0004257. [Google Scholar]
  4. Turner M, , 2003. The role of mannose-binding lectin in health and disease. Mol Immunol 40: 423429. [Google Scholar]
  5. Jack DL, Klein NJ, Turner MW, , 2001. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180: 8699. [Google Scholar]
  6. Jensenius H, Klein DCG, van Hecke M, Oosterkamp TH, Schmidt T, Jensenius JC, , 2009. Mannan-binding lectin: structure, oligomerization, and flexibility studied by atomic force microscopy. J Mol Biol 391: 246259. [Google Scholar]
  7. Rassi A, Marcondes de Rezende J, , 2012. American trypanosomiasis (Chagas disease). Infect Dis Clin North Am 26: 275291. [Google Scholar]
  8. WHO. Chagas Disease (American trypanosomiasis). Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs340/en/. Accessed June 13, 2015.
  9. Pereira KS, Schmidt FL, Guaraldo AMA, Franco RMB, Dias VL, Passos LAC, , 2009. Chagas’ disease as a foodborne illness. J Food Prot 72: 441446. [Google Scholar]
  10. Malik LH, Singh GD, Amsterdam EA, , 2015. Chagas heart disease: an update. Am J Med 128: 1251.e71251.e9. [Google Scholar]
  11. Moncayo A, Silveira AC, , 2009. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104 (Suppl): 1730. [Google Scholar]
  12. Bern C, Montgomery SP, , 2009. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52e54. [Google Scholar]
  13. Benziger CP, do Carmo GAL, Ribeiro ALP, , 2017. Chagas cardiomyopathy. Cardiol Clin 35: 3147. [Google Scholar]
  14. Cantey PT, 2012. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52: 19221930. [Google Scholar]
  15. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MOC, , 2012. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9: 576589. [Google Scholar]
  16. Rassi A, Little WC, , 2000. Chagas’ heart disease. Clin Cardiol 23: 883889. [Google Scholar]
  17. Malik LH, Singh GD, Amsterdam EA, , 2015. The epidemiology, clinical manifestations, and management of Chagas heart disease. Clin Cardiol 38: 565569. [Google Scholar]
  18. Roberts A, Kemp C, , 2005. Chagas’ disease (American trypanosomiasis). J Am Acad Nurse Pract 13: 152153. [Google Scholar]
  19. Luz PR, Miyazaki MI, Neto NC, Nisihara RM, Messias-Reason IJ, , 2010. High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas Disease. Int J Cardiol 143: 448450. [Google Scholar]
  20. Cestari I dos S, Krarup A, Sim RB, Inal JM, Ramirez MI, , 2009. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol Immunol 47: 426437. [Google Scholar]
  21. Beltrame MH, Boldt ABW, Catarino SJ, Mendes HC, Boschmann SE, Goeldner I, Messias-Reason I, , 2015. MBL-associated serine proteases (MASPs) and infectious diseases. Mol Immunol 67: 85100. [Google Scholar]
  22. Dutra WO, Rocha MOC, Teixeira MM, , 2005. The clinical immunology of human Chagas disease. Trends Parasitol 21: 581587. [Google Scholar]
  23. Luz PR, Boldt ABW, Grisbach C, Kun JFJ, Velavan TP, Messias-Reason IJT, , 2013. Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease. PLoS One 8: e60237. [Google Scholar]
  24. Boldt ABW, Luz PR, Messias-Reason IJT, , 2011. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 140: 6370. [Google Scholar]
  25. Lidani KCF, Beltrame MH, Luz PR, Sandri TL, Nisihara RM, de Messias-Reaso IJ, , 2015. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease? Int J Cardiol 190: 233235. [Google Scholar]

Data & Media loading...

  • Received : 06 Sep 2017
  • Accepted : 13 Apr 2018
  • Published online : 03 Dec 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error